Phase I, Double-Blind, Placebo-Controlled, Ascending, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of SRX246 Capsules in Healthy Adult Volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2010
At a glance
- Drugs SRX 246 (Primary)
- Indications Heart failure; Traumatic stress disorders
- Focus Adverse reactions
- 18 Mar 2010 Actual patient number (49) added as reported by ClinicalTrials.gov.
- 23 Jan 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 23 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.